L&T Technology Services Limited (LTTS) a leading global pure-play engineering services company, has announced a collaboration with NVIDIA to develop software-defined architectures for medical devices focused on endoscopy, which will enhance the image quality and scalability of products.
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components. The architecture is a scalable platform that supports multiple applications, providing a real-time decision-making tool for the medical fraternity.
Developed from the ground up, the architecture boasts an image processing pipeline for noise reduction, edge and contrast enhancement, texture and color enhancement, and speckle correction. What sets it apart is its inclusion of Al/ML models developed for the detection, identification, and classification of polyps – abnormal growths often found dudng colonoscopies. The solution further impresses with its user-friendly interface and seamless integration of the image processing pipeline for visualization. It promises low-latency data transfer, superior image processing without performance bottlenecks, and scalability.
The collaboration leverages the NVIDIA Holoscan and NVIDIA IGX One platforms featuring ultra-low latency in data transfer, superior image processing, and scalability to support multiple Al-enabled applications. This helps ensure enhanced visualization for image processing and Al-based decision-making support, such as for polyp detection and classification.
“The combination of LTTS’ expertise in medical-device development and NVIDIA’s full-stack edge Al computing platform delivers unprecedented value to the medical technology industry by accelerating the development of Al-enabled, software-defined medical devices,” Shanker Trivedi, Senior Vice President of Enterprise Business, NVIDIA. “This collaboration provides a complete solution for customers looking to transition to a software-defined business model via real-time Al applications.”
“Our collaboration with NVIDIA helps us push the boundaries of what’s possible in medical imaging,” said Amit Chadha, CEO and Managing Director, L&T Technology Services. “The combination of the NVIDIA Holoscan software platform for edge Al inference and the NVIDIA IGX One hardware platform accelerates the development of Al-powered medical imaging solutions by enhancing image quality and real-time clinical decision-making support, making clinicians more efficient and improving patient outcomes.”